Hyalgan®: BIOIBERICA’ Hyaluronic Acid approved for medical use - Company news
 RSS | Register | Legal | Sitemap | Contact
Index Plant Phisiology - Bioiberica February 8, 2012
Company News
Products
The latest in...
Technical Information
Application to crops
Field Experience
Applied Physiology
User:
Password:
   
Register | Remember
Sello de calidad Medicina XXI
   
Hyalgan®: BIOIBERICA’ Hyaluronic Acid approved for medical use
November 3, 2001

BIOIBERICA'® Hyalganhas been approved as a medicine for the symptomatic treatment of knee arthrosis

Hyalgan® is a natural product based on hyaluronic acid, a substance present in the joint cartilage and synovial fluid (the liquid found inside the joint.) Hyaluronic acid acts as a shock absorber and joint lubricant. Hyalgan® is directly injected in the space between joints. Neither surgery nor hospitalization are needed. Hyalgan®efficiency has been proven by more than 45 clinical essays, which include more than 11,000 cases evidencing that this product has a double action, both mechanic as well as pharmacological. This action alleviates symptoms between 6 to 12 months after the end of the treatment.


The proven quality and security of this product by BIOIBERICA differentiates Hyalgan® from the other hyaluronic acids in the market that are sold as implants.





Company News | Application to crops | Products
Field Experience | Technical Information | Applied Physiology